- Home
- IMCC vs CARM Comparison
IMCC vs CARM Comparison
Compare IMCC & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- CARM
- Stock Information
- Founded
- IMCC 1980
- CARM 2016
- Country
- IMCC Israel
- CARM United States
- Employees
- IMCC N/A
- CARM N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- CARM Health Care
- Exchange
- IMCC Nasdaq
- CARM Nasdaq
- Market Cap
- IMCC 12.2M
- CARM 12.2M
- IPO Year
- IMCC N/A
- CARM N/A
- Fundamental
- Price
- IMCC $1.87
- CARM $0.40
- Analyst Decision
- IMCC
- CARM Hold
- Analyst Count
- IMCC 0
- CARM 5
- Target Price
- IMCC N/A
- CARM $0.90
- AVG Volume (30 Days)
- IMCC 74.1K
- CARM 25.4M
- Earning Date
- IMCC 08-12-2025
- CARM 11-06-2025
- Dividend Yield
- IMCC N/A
- CARM N/A
- EPS Growth
- IMCC N/A
- CARM N/A
- EPS
- IMCC N/A
- CARM N/A
- Revenue
- IMCC $38,430,631.00
- CARM $10,767,000.00
- Revenue This Year
- IMCC $47.12
- CARM N/A
- Revenue Next Year
- IMCC $12.83
- CARM N/A
- P/E Ratio
- IMCC N/A
- CARM N/A
- Revenue Growth
- IMCC 5.08
- CARM N/A
- 52 Week Low
- IMCC $1.29
- CARM $0.14
- 52 Week High
- IMCC $7.12
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- IMCC 32.26
- CARM 59.74
- Support Level
- IMCC $1.48
- CARM $0.30
- Resistance Level
- IMCC $2.48
- CARM $0.56
- Average True Range (ATR)
- IMCC 0.26
- CARM 0.05
- MACD
- IMCC -0.04
- CARM 0.02
- Stochastic Oscillator
- IMCC 34.45
- CARM 54.05
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.